v3.25.1
Fair Value of Financial Instruments
 3 Months Ended
Mar. 31, 2025
Fair Value Disclosures [Abstract]  
Fair Value of Financial Instruments Fair Value of Financial Instruments
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. For certain of the Company’s financial instruments, including certain cash equivalents, accounts receivable, accounts payable and accrued liabilities, the carrying amounts approximate their fair values due to the relatively short maturity of these balances.
The Company measures and reports certain cash equivalents, marketable securities, derivative foreign currency forward contracts at fair value in accordance with the provisions of the authoritative accounting guidance that addresses fair value measurements. This guidance establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. The hierarchy is broken down into three levels based on the reliability of inputs as follows:
Level 1 - Valuations based on quoted prices in active markets for identical assets or liabilities.
Level 2 - Valuations based on other than quoted prices in active markets for identical assets and liabilities, including quoted prices for identical assets or liabilities in less active or inactive markets, quoted prices for similar assets or liabilities in active markets, or inputs other than quoted prices that are observable for substantially the full term of the assets or liabilities.
Level 3 - Valuations based on inputs that are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability.
The Company's financial instruments consist of assets and liabilities measured using Level 1 and 2 inputs. Level 1 assets include a highly liquid money market fund, which is valued using unadjusted quoted prices that are available in an active market for an identical asset. Level 2 assets include fixed-income U.S. Treasury and government agency securities, commercial paper, corporate bonds, asset-backed securities and derivative financial instruments consisting of foreign currency forward contracts. The securities, bonds and commercial paper are valued using prices from independent pricing services based on quoted prices of identical instruments in less active or inactive markets, quoted prices of similar instruments in active markets, or industry models using data inputs such as interest rates and prices that can be directly observed or corroborated in active markets. The foreign currency forward contracts are valued using observable inputs, such as quotations on forward foreign exchange points and foreign interest rates.
The following table sets forth by level within the fair value hierarchy the fair value of the Company's financial assets and liabilities measured at fair value on a recurring basis:
March 31, 2025
Level 1Level 2Fair Value
(in thousands)
Money market funds$508 $— $508 
Commercial paper— 1,992 1,992 
U.S. Treasury and government agencies— 254,985 254,985 
Corporate bonds— 140,742 140,742 
Asset-backed securities— 5,640 5,640 
Foreign currency forward contracts— 555 555 
Total assets$508 $403,914 $404,422 
Foreign currency forward contracts$— $2,173 $2,173 
Total liabilities$— $2,173 $2,173 
December 31, 2024
Level 1Level 2Fair Value
(in thousands)
Money market funds$404 $— $404 
Commercial paper— 6,443 6,443 
U.S. Treasury and government agencies— 233,279 233,279 
Corporate bonds— 131,812 131,812 
Asset-backed securities— 7,520 7,520 
Foreign currency forward contracts— 2,575 2,575 
Total assets$404 $381,629 $382,033 
Foreign currency forward contracts$— $1,339 $1,339 
Total liabilities$— $1,339 $1,339 
There were no transfers between Level 1, Level 2 and Level 3 categories during the three months ended March 31, 2025 and 2024.
Cash equivalent and investments
The Company's cash equivalents and marketable securities consist of the following:
March 31, 2025
Amortized CostUnrealized GainsUnrealized LossesFair Value
(in thousands)
Cash equivalents: (1)
Money market funds$508 $— $— $508 
U.S. Treasury and government agencies54,166 — (3)54,163 
Total54,674 — (3)54,671 
Short-term marketable securities:    
Commercial paper1,993 — (1)1,992 
Corporate bonds53,383 94 (10)53,467 
U.S. Treasury and government agencies94,584 186 (23)94,747 
Total149,960 280 (34)150,206 
Long-term marketable securities:
Corporate bonds86,860 461 (46)87,275 
Asset-backed securities5,575 65 — 5,640 
U.S. Treasury and government agencies105,906 235 (66)106,075 
Total198,341 761 (112)198,990 
Total$402,975 $1,041 $(149)$403,867 
(1)Excludes cash of $236.0 million.
December 31, 2024
Amortized CostUnrealized GainsUnrealized LossesFair Value
(in thousands)
Cash equivalents: (2)
Money market funds$404 $— $— $404 
Commercial paper1,983 — — 1,983 
U.S. Treasury and government agencies33,939 4 — 33,943 
Total36,326 4 — 36,330 
Short-term marketable securities:
Commercial paper4,459 3 (2)4,460 
Corporate bonds47,155 107 (3)47,259 
U.S. Treasury and government agencies97,338 207 (23)97,522 
Total148,952 317 (28)149,241 
Long-term marketable securities:
Corporate bonds84,414 310 (171)84,553 
Asset-backed securities7,426 94 — 7,520 
U.S. Treasury and government agencies101,834 178 (198)101,814 
Total193,674 582 (369)193,887 
Total$378,952 $903 $(397)$379,458 
(2)Excludes cash of $195.9 million.
The following table summarizes the gross unrealized losses and fair value of the Company's marketable securities that were in an unrealized loss position aggregated by length of time:
March 31, 2025
Less than 12 months12 months or longerTotal
Fair ValueGross Unrealized LossesFair ValueGross Unrealized LossesFair ValueGross Unrealized Losses
(in thousands)
Commercial paper$1,992 $(1)$— $— $1,992 $(1)
Corporate bonds26,613 (56)— — 26,613 (56)
U.S. Treasury and government agencies112,453 (92)— — 112,453 (92)
Total$141,058 $(149)$— $— $141,058 $(149)
December 31, 2024
Less than 12 months12 months or longerTotal
Fair ValueGross Unrealized LossesFair ValueGross Unrealized LossesFair ValueGross Unrealized Losses
(in thousands)
Commercial paper$4,464 $(2)$— $— $4,464 $(2)
Corporate bonds27,154 (171)672 (3)27,826 (174)
U.S. Treasury and government agencies64,517 (221)— — 64,517 (221)
Total$96,135 $(394)$672 $(3)$96,807 $(397)
The Company considered the extent to which any unrealized losses on its marketable securities were driven by credit risk and other factors, including market risk, and if it is more-likely-than-not that the Company would have to sell the security before the recovery of the amortized cost basis. At March 31, 2025 and December 31, 2024, the unrealized losses related to its marketable securities were due to market factors other than credit. The Company does not believe the unrealized losses represent credit risk, and the Company does not intend to sell any of the securities in an unrealized loss position and it is not likely that the Company would be required to sell these securities before recovery of their amortized cost basis, which may be at maturity. Thus, no credit loss was recognized for the Company's marketable securities for the three months ended March 31, 2025 and 2024.
The following summarizes the fair value of marketable securities by contractual maturity:
March 31, 2025
Amortized CostFair Value
(in thousands)
Due within One Year$204,634 $204,877 
Due after One Year through Five Years192,766 193,350 
Asset-backed securities5,575 5,640 
Total$402,975 $403,867 
Non-Marketable Securities
During the fiscal year ended December 31, 2018, the Company invested $2.5 million in preferred stock of a privately-held company. The fair value of the investment is not readily available, and there are no quoted market prices for the investment. The Company accounts for the investment at cost less impairment and will measure the investment at fair value when the Company identifies observable price changes. The investment is assessed for impairment whenever events or changes in circumstances indicate that the fair value of the investment is less than carrying value. During the second
quarter of 2023, the Company identified an observable price change in the investment and recognized an immaterial unrealized loss in other income (expense), net of the condensed consolidated statement of operations. The investment is included in other noncurrent assets on the condensed consolidated balance sheets. The Company has not received any dividends from the investment.
Derivative Financial Instruments
Designated cash flow hedges
The Company enters into foreign currency forward contracts to reduce the risk of variability in future cash flow due to foreign currency exchange rate fluctuation from certain forecasted subscription revenue orders billed in British Pound ("GBP") and Euro ("EUR") and operating expenses incurred in Indian Rupee ("INR"), which are designated as cash flow hedges. Hedge effectiveness is assessed at inception and at each reporting period utilizing regression analysis. Unrealized foreign exchange gains or losses related to those designated cash flow hedge contracts are recorded in accumulated other comprehensive income ("AOCI") and will be reclassified into revenues or operating expenses, respectively, in the same periods when the hedged transactions are recognized in earnings.
As of March 31, 2025, the Company had designated cash flow hedge forward contracts with notional amounts of €49.1 million, £21.6 million and Rs.4,579.0 million. As of December 31, 2024, the Company had designated cash flow hedge forward contracts with notional amounts of €51.4 million, £20.3 million and Rs.4,381.0 million.
As of March 31, 2025, an immaterial amount of net unrealized gain before tax on the foreign currency forward contracts for GBP and EUR reported in AOCI is expected to be reclassified into revenue within the next 12 months. As of March 31, 2025, an immaterial amount of net unrealized loss before tax on the foreign currency forward contracts for INR reported in AOCI is expected to be reclassified into operating expenses within the next 12 months.
Non-designated forward contracts
The Company also uses foreign currency forward contracts to hedge certain foreign currency denominated assets or liabilities, which are not designated as cash flow hedges. Unrealized foreign exchange gain or losses related to the non-designated forward contracts are recorded in other income (expenses), net and offset the foreign exchange gain or loss on the underlying net monetary assets or liabilities.
As of March 31, 2025, the Company had non-designated forward contracts with notional amounts of €18.7 million, £7.3 million, and Rs.1,650.0 million. As of December 31, 2024, the Company had non-designated forward contracts with notional amounts of €27.0 million, £8.0 million, Rs.1,252.0 million, and Canadian Dollar ("C$" or "CAD") C$1.0 million.
The following summarizes the fair value of derivative financial instruments as of March 31, 2025 and December 31, 2024:
March 31,
2025		December 31,
2024
(in thousands)
Assets
Foreign currency forward contracts designated as cash flow hedge$549 $2,495 
Foreign currency forward contracts not designated as hedging instruments6 80 
Total$555 $2,575 
Liabilities
Foreign currency forward contracts designated as cash flow hedge$2,034 $1,315 
Foreign currency forward contracts not designated as hedging instruments139 24 
Total$2,173 $1,339 
The Company presents its derivative assets and derivative liabilities at gross fair values in the condensed consolidated balance sheets. However, under the master netting agreements with the respective counterparties of the foreign exchange contracts, subject to applicable requirements, the Company is allowed to net settle transactions of the same currency with a
single net amount payable by one party to the other. The potential offset to both assets and liabilities under the right of set-off associated with the Company's foreign currency exchange contracts are immaterial as of March 31, 2025 and December 31, 2024. The derivatives held by the Company are not subject to any credit contingent features negotiated with its counterparties. The Company is not required to pledge nor is entitled to receive cash collateral related to the above contracts. The counterparties to these derivatives are large, global financial institutions that the Company believes are creditworthy, and therefore, it does not consider the risk of counterparty nonperformance to be material.
The following summarizes the gains (losses) recognized from forward contracts and other foreign currency transactions in other income (expense), net in the condensed consolidated statements of operations:
Three Months Ended
March 31,
20252024
(in thousands)
Net gains (losses) from non-designated forward contracts$(1,617)$512 
Other foreign currency transactions gains (losses)1,877 (1,941)
Total foreign exchange gains (losses), net$260 $(1,429)